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OBJECTIVES The goal of this study was to validate the prognostic value of the drop in heart rate (HR) after
exercise, compare it to other test responses, evaluate its diagnostic value and clarify some of
the methodologic issues surrounding its use.
BACKGROUND Studies have highlighted the value of a new prognostic feature of the treadmill test—rate of
recovery of HR after exercise. These studies have had differing as well as controversial results
and did not consider diagnostic test characteristics.
METHODS All patients were referred for evaluation of chest pain at two university-affiliated Veterans
Affairs Medical Centers who underwent treadmill tests and coronary angiography between
1987 and 1999 were determined to be dead or alive after a mean seven years of follow-up.
All-cause mortality was the end point for follow-up, and coronary angiography was the
diagnostic gold standard.
RESULTS There were 2,193 male patients who had treadmill tests and coronary angiography. Heart rate
recovery at 2 min after exercise outperformed other time points in prediction of death; a
decrease of22 beats/min had a hazard ratio of 2.6 (2.4 to 2.8 95% confidence interval). This
new measurement was ranked similarly to traditional variables including age and metabolic
equivalents for predicting death but failed to have diagnostic power for discriminating those
who had angiographic disease.
CONCLUSIONS Heart rate at 1 or 2 min of recovery has been validated as a prognostic measurement and
should be recorded as part of all treadmill tests. This new measurement does not replace, but
is supplemental to, established scores. (J Am Coll Cardiol 2001;38:1980–7) © 2001 by the
American College of Cardiology
Recent studies have highlighted the prognostic value of an
exercise treadmill test feature—heart rate (HR) recovery or
the rate of decrease in HR after an exercise test (1–3). While
earlier physiologic studies suggested a rapid HR recovery
response to exercise to be a marker of physical fitness, only
recently has its prognostic value been reported. The rate of
HR return to baseline after exercise is theorized to be due to
high vagal tone associated with fitness and good health.
As with any new finding, it is essential to validate its
reproducibility and applicability in other populations as well
as to demonstrate what methodology is required to obtain
similar results. Heart rate recovery has been shown to be
prognostic usually at 1 or 2 min after exercise in populations
referred for standard exercise testing (1), referred for nuclear
testing (2) and with the use of submaximal protocols (3), but
the threshold value for an abnormal test (cut-point) has
varied. In one previous study, the protocol used was staged
with a cool-down walk, yet current guidelines suggest that
ramp-testing and rapid supine patient placement after the
exercise test offer advantages over other methods and should
be considered (4). The effect of beta-blockers, the optimal
time point in recovery to measure HR drop, as well as the
appropriate cut-point to assess the magnitude of the de-
crease in HR remain unresolved. Moreover, while the
prognostic value of HR recovery has been highlighted, its
relative value compared with other treadmill responses and
its diagnostic value remain uncertain.
The purpose of this study was to validate this measure-
ment, compare it with other test responses, evaluate its
diagnostic value and clarify some of the methodologic issues
surrounding its use.
METHODS
Population. A total of 8,000 male patients underwent
treadmill testing at two Veterans Affairs Medical Centers
between 1987 and 1998. Of these, 3,454 were evaluated for
chest pain with coronary angiography within three months
of treadmill testing. Patients with previous cardiac surgery
or angiography, valvular heart disease, left bundle branch
block, paced rhythms or Wolff-Parkinson-White on their
resting electrocardiogram were excluded from the study.
Remaining were 2,193 patients for survival analysis; after
excluding those with previous myocardial infarction (MI) by
history or by Q waves, there was a subgroup of 1,282. While
the total remaining patients are appropriate for prognostic
assessment, the evaluation of the diagnostic properties of a
test should be performed in the subgroup without MI (4).
Exercise testing. Patients underwent symptom-limited
treadmill testing using the U.S. Air Force School of
Aerospace Medicine (5) or an individualized ramp treadmill
protocol (6). The physiologic distinction of these protocols
is that the patient is subjected to small, frequent increments
in workload rather than uneven increases every 3 min.
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Information gathered from a questionnaire enabled maxi-
mal exercise to be reached at approximately 10 min (7).
Patients did not perform a cool-down walk but were placed
supine as soon as possible after exercise. The reasons for
termination were angina, 2 mm of abnormal ST depres-
sion, drop in systolic blood pressure or ominous arrhyth-
mias. Visual ST-segment depression was measured at the J
junction and corrected for pre-exercise ST-segment depres-
sion. An abnormal response was defined as 1 mm or more of
horizontal or downsloping ST-segment depression. Blood
pressure was taken manually, and metabolic equivalents
(METs) were estimated from treadmill speed and grade.
Heart rate was measured supine, standing, during each
minute of exercise, at maximum exercise and in recovery at
1, 2, 3 and 5 min. Heart rate recovery was defined as
(maximum HR—HR at specified time period after exercise)
and represented the drop in HR during that time interval.
No test was classified as indeterminate (8); medications
were not withheld, and maximal HR target was not used as
an end point. The exercise tests were performed, analyzed
and reported with a standard protocol utilizing a comput-
erized database.
Coronary angiography. Coronary artery narrowing was
visually estimated and expressed as percent lumen diameter
stenosis. Patients with a 50% narrowing of the left main, left
anterior descending, left circumflex or right coronary arter-
ies or their major branches were considered to have signif-
icant angiographic coronary artery disease (CAD). Severe
disease was considered to be two-vessel disease if the
proximal left anterior descending was involved; otherwise,
three-vessel or left main disease were considered severe. The
50% criterion was chosen to be consistent with definitions
used by the Coronary Artery Bypass Graft Surgery Trialists’
Collaboration (9). In addition, the Duke coronary artery
jeopardy score was calculated (10). Ejection fraction was
estimated from biplane left ventricular angiograms. Deci-
sions for cardiac catheterization were consistent with clinical
practice.
Follow-up. The social security death index was used to
match all of the patients’ names to their social security
numbers. The index was updated weekly, and the most
current records were used. Death status was determined as
of July 2000 and was 100% complete. No other information
regarding hospitalizations, cardiac interventions or cause of
death during the follow-up was known.
Statistical methods. All-cause mortality was used as the
end point for follow-up, and coronary angiography was
utilized for diagnostic gold standard.
Survival analysis was performed using Kaplan-Meier
curves to compare variables and cut-points, and the Cox
hazard function was used to demonstrate which variables
were independently and significantly associated with death.
Automatic selection of variables was performed with a Z
value cutoff of 2 and 20 iterations. Hazard ratios were
calculated along with their 95% confidence intervals.
Logistic regression was used to separate subjects into
those with and without significant angiographic disease,
based on clinical and measured exercise variables in the
diagnostic subpopulation. Forward selection was used with
entry at a significance level 0.05. The general linear
logistic regression model used took the following form:
Probability (0 to 1)  1 / (1  e[abxcy. . .])
where a is the intercept, b and c are coefficients and x and y
are variable values.
How well the models separated patients with and without
a given outcome (abnormal angiogram or death) was as-
sessed by means of the area under a receiver operating
characteristic (ROC) curve, which ranged from 0 to 1, with
0.5 corresponding to no discrimination (i.e., random per-
formance) and 1.0 to perfect discrimination.
Number Crunching System Software (Salt Lake City,
Utah) was used for all statistical analyses.
RESULTS
Patient characteristics. This male study population had a
mean height of 69.6 in. (2.9 in.), a mean weight of 191 lbs
(34 lbs) and a mean body mass index of 28  9. Average
resting HR was 76  14 beats/min, with a corresponding
mean systolic blood pressure of 125  20 mm Hg. Regard-
ing medications, 4.4% reported taking digoxin, and 34%
were taking beta-blockers. No significant differences in
these parameters were noted between those who survived
and those who died. Other relevant variables for the entire
population, for those who survived and the 413 patients who
died over the mean seven-year (median six) follow-up are
presented with significance levels in Table 1. There was an
average annual mortality of 2%.
Exercise test responses. No complications were encoun-
tered during testing. Results for the entire population, and
specifically for those who survived and the 413 patients who
died, along with significance levels for differences are pre-
sented in Table 2.
Validation of prior criteria. Our first examination of HR
recovery was to apply the previously published threshold
values for abnormal at the specified time points. Figure 1
illustrates the Kaplan-Meier curves for three criteria (12
beats/min drop at 1 min after exercise, 18 beats/min drop at
1 min after exercise and 42 beats/min drop at 2 min after
exercise), showing a significant ability of all criteria to
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predict mortality (1–3). Significant hazard ratios were asso-
ciated with each specified criterion.
Best time/cut-point. In order to compare the candidate
cut-points with each other and with the published cut-
points in this population, they were entered into a propor-
tional hazards regression model with automatic selection.
Heart rate recovery measurements at 2 min recovery were
superior to all other time periods, and a value of 22
beats/min was optimal at that time period as judged by the
Z values and significance levels. Figure 2 shows a Kaplan-
Meier plot of this criterion for comparison with previously
published cut-points presented in Figure 1.
The effect of beta-blockers and maximal HR. Previous
results have been divided over the effects of beta-blockers.
We found no difference in the Kaplan-Meier survival curves
of those receiving beta-blockers when compared with those
not receiving beta-blockers when both exhibited abnormal
HR in recovery. The Kaplan-Meier curves in Figure 3
demonstrate no difference in the prognostic value of our
optimal criteria of a drop of 22 beats/min at 2 min whether
or not patients were receiving beta-blockers. When beta-
blocker administration was confirmed by not reaching target
HR, the same result was obtained. In addition, the same
result was obtained in those who did and those did not
obtain target HR.
Comparison with other variables. We then determined
how HR recovery ranks with traditional treadmill responses.
To do this, we entered all of the traditional treadmill
responses and several clinical variables that were univariately
significant (resting HR and blood pressure along with HR
recovery) into a proportional hazards regression model. The
top variables chosen as significant predictors were METs,
age, history of typical angina and HR drop at 2-min
recovery. Notably, the treadmill angina index and exercise-
induced ST depression—both ischemic variables—were not
chosen.
Prognostic score. Because the ischemic components of the
Duke treadmill score were not predictive of all-cause mor-
Table 1. Population Characteristics With Univariate Comparison Between Those Who Died
and Those Who Survived
Total Sample
n  2,193 (%)
Survived
n  1,780 (%)
Died
n  413 (%) p Value
Age (mean) 59  10 58  10 63  8 0.001
Age  65 yrs 756 (34.5) 547 (30.7) 209 (50.6) 0.001
BMI (mean) 28  9 28  4 27  18 0.45
MI by history or by ECG 912 (41.6) 692 (38.9) 220 (53.3) 0.01
Resting ST depression 393 (17.9) 297 (16.7) 96 (23.2) 0.001
History of typical angina 854 (39.1) 646 (36.5) 208 (50.4) 0.001
Digoxin 96 (4.4) 53 (3.0) 43 (10.4) 0.001
Beta-blockers 745 (34.0) 611 (34.3) 134 (32.4) 0.46
Stroke 87 (4.0) 56 (3.1) 31 (7.5) 0.001
Pulmonary disease 136 (6.2) 90 (5.1) 46 (11.1) 0.001
CHF 177 (8.1) 109 (6.1) 68 (16.5) 0.001
Diabetes 337 (15.4) 267 (15.0) 70 (16.9) 0.32
Ever smoked 1,453 (66.2) 1,207 (67.8) 246 (59.5) 0.001
LVH 65 (3.0) 34 (1.9) 31 (7.5) 0.001
Any CAD by angiography 1,538 (70.1) 1,190 (66.9) 348 (84.3) 0.001
Severe CAD by angiography 651 (29.7) 468 (26.3) 183 (44.3) 0.001
Duke coronary jeopardy score (mean) 4.53  4.0 4.18  4.0 6.02  4.0 0.001
Ejection fraction 62  13 62.7  12 59  16 0.001
BMI body mass index; CAD coronary artery disease; CHF congestive heart failure; ECG electrocardiogram; LVH
left ventricular hypertrophy; MI  myocardial infarction.
Table 2. Treadmill Test Responses With Univariate Comparison Between Those Who Died
and Those Who Survived
Total Sample
n  2,193 (%)
Survived
n  1,780 (%)
Died
n  413 (%) p Value
Angina occurred 589 (26.9) 487 (27.4) 102 (24.7) 0.3
Angina reason for stopping 310 (14.1) 255 (14.3) 55 (13.3) 0.63
Predicted METs 5 548 (25.0) 380 (21.3) 168 (40.7) 0.001
Exercise-induced ST depression (1 mm) 854 (38.9) 663 (37.2) 191 (46.2) 0.001
Maximal HR 125  23 126  23 121  21 0.001
Maximal SBP 169  29 164  29 161  30 0.06
Drop in HR at 1 min recovery 11.2  8.0 11.8  8.2 8.9  7.0 0.001
Drop in HR at 2 min recovery 31.7  13.1 33.1  12.9 25.8  12.4 0.001
Drop in HR at 3 min recovery 40.2  14.7 41.5  14.5 34.9  14.5 0.001
Drop in HR at 5 min recovery 42.7  15.2 43.8  15.0 37.9  15.1 0.001
HR  heart rate; METs  metabolic equivalents; SBP  systolic blood pressure.
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tality, we elected to consider the combined use of METS
and HR recovery. Figure 4 presents a Kaplan-Meier plot
using a METS criterion of 5 and HR recovery criterion of
22 beats/min as well as for abnormal by both criteria.
We also created a prognostic score using the variables
chosen in the Cox hazard model and their coefficients as
follows:
Age (years) 10  definite angina pectoris (0 no, 1 yes)
HR drop at 2 min recovery 5  METs
We chose cut-points in this prognostic score by which to
stratify patients into high-, intermediate- and low-risk as
illustrated in Figure 5. The high-risk group had a hazards
ratio of greater than five times. The score was entered along
with data from cardiac catheterization into a proportional
hazards regression model with automatic selection. The
above score was chosen first with a Z value of 13.3 (p 
0.001) followed by ejection fraction with a Z value of 3 (p
0.002) and, finally, the Duke jeopardy score with a Z value
of 2.6 (p  0.01). When cardiac catheterization variables
were added to the Cox hazard model, they were superceded
by the score variables.
Diagnostic characteristics. The diagnostic value of HR
recovery (i.e., prediction of the presence of significant
angiographic disease) was addressed in the subpopulation
without MI. There was a 59% prevalence of significant
angiographic CAD. When HR recovery was entered into
the logistic regression model with variables previously noted
to predict angiographic coronary disease (including maximal
HR, ST depression, age and chest pain characteristics)
(11,12), it was not chosen. The area under the curve of an
Figure 3. Kaplan-Meier survival curves for 2 min post/22 beats/min drop
according to beta-blocker status.
Figure 1. Kaplan-Meier survival curves for the three published criteria for
heart rate recovery: (Top) 1 min post/12 beats/min drop, (Middle) 1 min
post/18 beats/min drop and (Bottom) 2 min post/42 beats/min drop.
Figure 2. Kaplan-Meier survival curve for the 2 min post/22 beats/min
drop criterion found to be optimal in our study.
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ROC curve plotted with any of the continuous HR recovery
measurements was never 0.58 (p  0.001) as compared
with the area under the ROC curve obtained for the ST
response alone (0.67) or that from a previously published
diagnostic score (0.79) (11).
DISCUSSION
Heightened activation of the renin-angiotensin-sympathetic
nervous system (RAS) at rest is associated with adverse
outcomes in cardiovascular disease (13). The RAS hyper-
activity has been shown to predict death in congestive heart
failure, as demonstrated by studies of neurohormonal me-
diators, HR variability and baroreflex sensitivity (14). Re-
cent attention has been paid to manifestations of the RAS
and the balance between the sympathetic and parasympa-
thetic nervous system during exercise testing (15). During
exercise there is activation of the sympathetic nervous
system and withdrawal of parasympathetic activity; the
reverse occurs during recovery.
Previous studies. Recently, consideration has been given
to the role of HR in recovery as a predictor of mortality.
Heart rate recovery is mediated by vagal reactivation, and
the rate at which HR declines appears to be a reflection of
a faster recovery from the sympathetic drive necessary
during exercise (16). Increased vagal activity associated with
a faster HR recovery has been shown to be associated with
a decrease in risk of death (17). For this reason, several
recent studies have looked at HR recovery after exercise as
a prognostic tool. These studies are summarized in Table 3.
In the first study, Cole et al. (2) looked at 2,428 adults who
had been referred for exercise scintigraphy over six years.
They found that using a drop of 12 beats/min at 1 min
after exercise as the definition of an abnormal response, a
relative risk of 4.0 for death was observed. The group with
a value12 had a mortality of 19%, while the group with an
HR decrease 12 had a mortality of 5% over the six-year
period. The study employed the symptom-limited Bruce
protocol with a 2-min cool-down walk. Patients on beta-
blockers were included in the study, and no difference was
seen in the ability of the test to discriminate between low-
and high-risk patients in those patients on beta-blockers.
The investigators used all-cause mortality and performed
survival analysis with and without censoring of interventions
(coronary artery bypass grafting [CABG] and percutaneous
transluminal coronary angioplasty [PTCA]) and found no
difference in results.
These investigators then studied a different patient pop-
ulation (3). Asymptomatic patients enrolled in the Lipid
Research Clinics Prevalence study underwent exercise test-
ing using a Bruce protocol. The tests were stopped when
85% to 90% of peak HR was achieved, and no cool-down
period was allowed. Heart rate recovery was measured at 2
min after exercise. Heart rate recovery continued to be a
strong predictor of all-cause mortality; patients with an
abnormal value had a mortality rate of 10%, while patients
with a normal value had a mortality rate of 4% at 12 years
of follow-up. Given the differences in methods, direct
comparisons between the two studies were not possible, but
this second study confirmed HR recovery as a powerful
prognostic measurement.
To further elucidate the power of HR recovery in distinct
populations, these investigators then published another
study using patients referred for standard exercise treadmill
testing (1). Using the same methods as the original study,
the investigators found similar results, although, notably,
the cut-off value for an abnormal test was different. Patients
with an abnormal HR recovery had 8% mortality at 5.2
years, whereas patients with a normal HR recovery had only
2% mortality. Neither this nor the previous study censored
for CABG or PTCA, and this study had 8% of patients
with CABG enrolled along with 75% asymptomatic indi-
viduals. The investigators also compared the prognostic
ability of HR recovery to that of the Duke treadmill score.
While the individual components of the Duke score (except
exercise capacity) did not have prognostic power, the score
produced similar survival curves to HR recovery and, in
patients with abnormal scores on both tests, survival was
even further compromised.
This study. In our study, we attempted again to validate
the use of HR recovery for prognosis in a male veteran
population. The mortality rate in our study was higher than
Figure 4. Kaplan-Meier survival curves for the criteria of 2 min post/22
beats/min drop or5 metabolic equivalents (METS) exercise capacity and
for patients who fulfilled both criteria. HRR  heart rate drop at 2 min
post exercise.
Figure 5. Kaplan-Meier survival curves for the three levels of risk stratifi-
cation according to the score.
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Table 3. Previously Published Prognostic Studies Relating to the Decrease of HR After Exercise
Study Population
Sample Size
(% Women) Exclusion Criteria
Follow-Up
(y-mean)
Test Protocol/
Recovery Status
Minutes of Recovery/
Cut-Point
Mortality
(All-Cause)
Sensitivity/Specificity
for Death
Other Variables
Studied Beta-Blocker Status
Cole et al.
(2)*
Referral for exercise
perfusion; 9%
with known
CAD
2,428 (37) CABG, angiography,
CHF/digoxin use, LBBB
6 Bruce, with 2 min cool-
down; Symptom-limited
1 min/
12 beats/min
213 (9%) (cut-point  12 beats/
min) 56%/77%; (cut-
point  8 beats/min)
33%/90%
METS, male gender,
age, perfusion
defects on
scintigraphy,
chronotropic
incompetence
Used by 12% of study
population; No
association with
abnormal test
Cole et al.
(3)
Participants in
Lipid Research
Clinics
Prevalence study,
asymptomatic
5,234 (39) Beta-blockers, other cardiac
meds, history of
cardiovascular disease
12 Bruce, without cool-down;
85% age-predicted HR
2 min/
42 beats/min
325 (6.2%),
36% felt to be
cardiovascular
follow-up
100%
54%/69% No comparison Excluded
Nishime et al.
(1)
Referral for ETT;
8% prior CABG,
75% screening
asymptomatic,
9% prior MI
9,454 (22) CHF, LBBB, digoxin,
valvular heart disease
5.2 Bruce, with 2 min cool-
down; symptom-limited
1 min/
12 beats/min
312 (3%) 49%/81% METS, maximal
HR, Duke
treadmill score;
TM AP score and
El-ST depression
not prognostic
HR recovery not
predictive of death
in beta-blocker
group
Shetler
(present
study)
Referral for
standard ETT;
42% with prior
MI
2,193 (all
men)
CABG, angiography,
LBBB, pacer
6.8 Ramp without cool-down;
symptom limited
2 min/
22 beats/min
413 (19%) 35%/83% Age, METS, history
of typical angina;
treadmill AP score
and El-ST
depression not
prognostic
Used by 34% of the
study population;
HR recovery
equally predictive
AP  angina pectoris; CABG  coronary artery bypass grafting; CAD  coronary artery disease; CHF  congestive heart failure; El  elevated; ETT  exercise treadmill test; HR  heart rate; LBBB  left bundle branch block;
METS  metabolic equivalents; MI  myocardial infarction.
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it was in previous studies of HR recovery. Using similar
statistical analyses, we found that a decrease of HR in
recovery of 22 beats/min at 2 min after exercise identified
a high-risk group of patients. While these data confirm the
utility of HR recovery, it is important to note that several
studies have employed different cut-points for defining an
abnormal test, even when the testing protocol (e.g., presence
or absence of cool-down, minute of recovery when measure-
ments are made) are the same. Therefore, it is difficult to
know which value is most applicable to the general popu-
lation.
Beta-blockade. We also found that the clinical adminis-
tration of beta-blockers had no significant impact on the
prognostic value of HR recovery. Given the impact of
beta-blockers on the ability to achieve maximum HR, it
would not be unreasonable to imagine that the medication
might have an impact on HR recovery. However, the same
results were found in those who reached target HR and
those who did not. Further analysis of this issue would be
warranted to better understand the true impact of this
medication and maximal HR.
Multivariable analysis. Through multivariate analysis, we
evaluated the power of several other clinical and treadmill
variables to see how they compared with HR recovery in
their ability to predict outcome. Similar to Cole et al. (2), we
found that a low MET capacity was the most powerful
variable associated with outcome. This finding was not
shared by Nishime et al. (1), in which the strongest
predictor of death was resting tachycardia. It is important to
note that in our study and those of Nishime et al. (1) and
Cole et al. (3), ischemic ST responses on the treadmill did
not predict death. Exercise-induced angina was also not a
significant variable in the study by Nishime et al. (1) nor in
our study. The Duke treadmill score (18) includes both of
these variables, and they have been predictors of cardiovas-
cular outcome in several other studies.
This raises the question as to why ischemic variables
included in the Duke score that clearly have diagnostic
power do not predict all-cause mortality. While all-cause
mortality has advantages over cardiovascular mortality as an
end point (19), the Duke score was generated using the end
points of infarction and cardiovascular death (18). Further-
more, cardiology interventions such as bypass surgery or
catheter interventions were censored in the Duke study (i.e.,
subjects were removed from the survival analysis when these
events occurred). Such censoring should increase the asso-
ciation of ischemic variables with outcome by removing
patients whose disease has been alleviated and, thereby,
would not be as likely to experience the outcome. We did
not censor patients in this study on the basis of whether or
not they had a cardiovascular procedure during follow-up
because we do not have that information. From a previous
study using a similar patient population, our group found
that 75% of deaths were cardiovascular deaths, and 20% of
patients were censored in follow-up due to bypass surgery
(20). If the proportions of these statistics are similar in our
current population, it would not be unreasonable to expect
a bias against the predictive power of these variables.
However, this hypothesis would need to be proven since
censoring had no impact on HR recovery findings in the
study that did censor (2) nor in the Duke score. In fact,
exercise-induced ST depression predicted all-cause mortal-
ity with and without censoring in an earlier study (21).
These contradictory results could potentially be due to the
more effective methods of treatment currently available for
coronary disease.
Diagnostic characteristics. A distinct advantage over pre-
vious studies is that we selected a group who underwent
coronary angiography. This made it possible to evaluate the
diagnostic ability of HR recovery. Surprisingly, HR recovery
was not selected among the standard variables to be in-
cluded in a logistic model, and the ROC curve did not
indicate any discriminatory value. Thus, while HR recovery
has been validated as an important prognostic variable, it did
not help the diagnosis of coronary disease in this study.
Study limitations. While our study was unique in its strict
adherence to guidelines in the performance of exercise
testing and its inclusion of angiographic data, there were
some limitations. The use of a ramp protocol differed from
previous studies using the Bruce protocol, but, rather than
being a limitation, this extends earlier findings to another
protocol. The lack of inclusion of women is quite important,
especially given the different characteristics of treadmill
testing between women and men that have previously been
shown. Additionally, we were unable to provide information
on cause of death and did not have information about
cardiovascular procedures during the follow-up period, so
we could not censor on them. As mentioned earlier, the
inability to censor may skew results. Without censoring, we
are predicting prognosis in spite of, or in addition to,
modern therapy rather than predicting who should have
interventions. The pathophysiology of an inadequate HR
decrease in recovery has not been explained by our study.
Finally, as mentioned previously, our angiographic subset
was subject to work-up bias.
Conclusions. We found that, among male patients with or
without prior MI but without prior bypass surgery referred
for clinical exercise testing done without cool-down walk
but with prompt supine placement, an HR drop of 22
beats/min at 2 min recovery had prognostic, but not
diagnostic, value. Heart rate at 1 or 2 min of recovery has
been validated as a prognostic treadmill measurement and
should be recorded as part of all treadmill tests. The
prognostic power of this measurement does not appear to be
affected by beta-blockade, but its cut-point is most likely
affected by population selection and protocol. A score
including HR recovery, METs, age and history of typical
angina pectoris was superior to cardiac catheterization data
for predicting prognosis. To date, this measurement has not
been evaluated as a diagnostic indicator, and we found that
it was not diagnostic of angiographic CAD. The drop of
HR in recovery or its score should supplement, but not
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replace, the Duke treadmill score that has been validated as
a predictor of infarct-free survival and diagnostic of angio-
graphic CAD. Though our analysis has not explained the
pathophysiology of an inadequate decline of HR after
exercise, it may well represent a marker of habitual physical
activity level (16).
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